Home > Financial Ratios > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ALEMBIC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.2735.24-23.09-41.0227.66

What is the latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS is 9.27 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.27
Mar202435.24
Mar2023-23.09
Mar2022-41.02
Mar202127.66

How is Core EBITDA Growth of ALEMBIC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 9.27
-73.69
Mar2024 35.24
Positive
Mar2023 -23.09
Negative
Mar2022 -41.02
Negative
Mar2021 27.66 -

Other Financial Ratios of ALEMBIC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of ALEMBIC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS ₹13,989.1 Cr -7.7% -9% -9.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


ALEMBIC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS

-7.7%

-9%

-9.2%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses